Respiratory syncytial virus infections+metapneumovirus

Clinical trials for Respiratory syncytial virus infections+metapneumovirus explained in plain language.

Never miss a new study

Get alerted when new Respiratory syncytial virus infections+metapneumovirus trials appear

Sign up with your email to follow new studies for Respiratory syncytial virus infections+metapneumovirus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could one shot stop RSV and hMPV? GSK begins human trials

Vaccine Recruiting now

This study tests an experimental vaccine from GSK that targets two respiratory viruses: RSV and hMPV. About 1,800 adults aged 18-80 will receive different doses to check safety and immune response. The goal is to see if a single shot can protect against both viruses, which can ca…

Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS

Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Vaccine

Last updated Aug 22, 2026 00:00 UTC

Respiratory syncytial virus infections+metapneumovirus

Get alerted when new Respiratory syncytial virus infections+metapneumovirus trials appear

Could one shot stop RSV and hMPV? GSK begins human trials